ClinicalTrialsFinder
Not Yet RecruitingPhase 4ACTRN12609000804280

The effect of N-acetylcysteine supplementation on cycling performance and adaptation to exercise in well-trained athletes

The effect of N-acetylcysteine on cycling performance and adaptation to exercise in well-trained athletes: a double blind randomised placebo controlled trial

Sponsor

University of Technology, Sydney

Enrollment

10 participants

Start Date

Oct 15, 2009

Study Type

Interventional

Conditions

Exercise adaptation

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 35 Yearss

Plain Language Summary

Simplified for easier understanding

This study investigates whether N-acetylcysteine (NAC) supplements affect cycling performance and training adaptation in well-trained athletes aged 18 to 35. Participants must be highly fit cyclists or triathletes who train 10 to 15 hours per week.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

This study has two 9-day intervention periods with a 3-week washout period between each intervention. The trial involves taking 1200 mg oral tablet of n-acetyl cysteine per day in addition to the part

This study has two 9-day intervention periods with a 3-week washout period between each intervention. The trial involves taking 1200 mg oral tablet of n-acetyl cysteine per day in addition to the participant's usual physical training.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000804280